A detailed history of Td Private Client Wealth LLC transactions in Organon & Co. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 376 shares of OGN stock, worth $5,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares
376
Previous 376 -0.0%
Holding current value
$5,745
Previous $7.78 Million 7.58%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $6,561 - $8,256
376 New
376 $7.78 Million
Q1 2024

Aug 16, 2024

BUY
$13.78 - $18.8 $5,181 - $7,068
376 New
376 $7.07 Million
Q4 2023

Aug 16, 2024

SELL
$10.95 - $17.32 $1,095 - $1,732
-100 Closed
0 $0
Q3 2023

Aug 16, 2024

SELL
$16.59 - $23.77 $13,421 - $19,229
-809 Reduced 89.0%
100 $1.74 Million
Q2 2023

Aug 16, 2024

SELL
$19.27 - $24.63 $366 - $467
-19 Reduced 2.05%
909 $18.9 Million
Q1 2023

Aug 16, 2024

SELL
$21.42 - $32.08 $2,763 - $4,138
-129 Reduced 12.2%
928 $21.8 Million
Q4 2022

Aug 16, 2024

SELL
$23.31 - $28.61 $5,244 - $6,437
-225 Reduced 17.55%
1,057 $29.5 Million
Q3 2022

Aug 16, 2024

BUY
$23.4 - $34.25 $4,984 - $7,295
213 Added 19.93%
1,282 $30 Million
Q2 2022

Aug 16, 2024

SELL
$31.66 - $38.9 $7,725 - $9,491
-244 Reduced 18.58%
1,069 $37.6 Million
Q1 2022

Aug 16, 2024

SELL
$30.45 - $39.36 $4,232 - $5,471
-139 Reduced 9.57%
1,313 $47.4 Million
Q4 2021

Aug 16, 2024

SELL
$28.67 - $37.13 $10,665 - $13,812
-372 Reduced 20.39%
1,452 $44.2 Million
Q3 2021

Aug 16, 2024

BUY
$28.63 - $35.64 $41,456 - $51,606
1,448 Added 385.11%
1,824 $59.8 Million
Q2 2021

Aug 16, 2024

BUY
$28.45 - $38.0 $42,589 - $56,886
1,497 Added 398.14%
1,873 $56.7 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.